Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy
NCT04637308
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
216
Enrollment
OTHER
Sponsor class
Conditions
Fluid Retention
Interventions
DRUG:
Succinylated gelatin
Sponsor
Guangdong Provincial People's Hospital